A Case Report of Severe Hypovolemic Hyponatremia Secondary to Angiotensin Receptor Blocker- thiazide Diuretic Usage
Mohammed Ziauddin, Mohammed Zabeer Uddin, Ummay Mariya & Tarannum Fatima · Asian Journal of Cardiology Research · 2025
Key Clinical Message: Telmisartan-hydrochlorthiazide is a US FDA and CDSCO approved oral Fixed Dose combination of ARB & Diuretic for treating hypertension as second line therapy. Telmisartan is an ARBs prevent angiotensin II acting on AT1 receptors and are similar to ACEIs,...
Open access
Research Article
10.9734/ajcr/2025/v8i1310